Morgan Stanley
MYOV

Morgan Stanley’s Myovant Sciences Ltd. MYOV Stock Holding History

Morgan Stanley’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-461,060
Closed -$12.4M – 7919
2022
Q4 		$12.4M Buy
461,060
+326,188
+242% +$8.58M ﹤0.01% 2858
2022
Q3 		$2.42M Sell
134,872
-120,927
-47% -$1.93M ﹤0.01% 4290
2022
Q2 		$3.18M Sell
255,799
-224,877
-47% -$2.48M ﹤0.01% 4145
2022
Q1 		$6.4M Buy
480,676
+134,274
+39% +$1.8M ﹤0.01% 3415
2021
Q4 		$5.39M Buy
346,402
+251,444
+265% +$4.8M ﹤0.01% 3639
2021
Q3 		$2.13M Sell
94,958
-145,098
-60% -$3.19M ﹤0.01% 4517
2021
Q2 		$5.46M Buy
240,056
+20,212
+9% +$425K ﹤0.01% 3684
2021
Q1 		$4.52M Sell
219,844
-74,164
-25% -$1.69M ﹤0.01% 3521
2020
Q4 		$8.12M Buy
294,008
+131,583
+81% +$2.56M ﹤0.01% 2737
2020
Q3 		$2.28M Buy
162,425
+72,371
+80% +$1.35M ﹤0.01% 3542
2020
Q2 		$1.86M Sell
90,054
-410,797
-82% -$5.59M ﹤0.01% 3666
2020
Q1 		$3.78M Buy
500,851
+463,570
+1,243% +$5.2M ﹤0.01% 2721
2019
Q4 		$578K Sell
37,281
-21,344
-36% -$215K ﹤0.01% 4846
2019
Q3 		$305K Sell
58,625
-15,712
-21% -$117K ﹤0.01% 4924
2019
Q2 		$673K Buy
74,337
+70,747
+1,971% +$1.06M ﹤0.01% 4445
2019
Q1 		$85K Buy
3,590
+2,312
+181% +$47.3K ﹤0.01% 5466
2018
Q4 		$21K Sell
1,278
-38,876
-97% -$766K ﹤0.01% 6003
2018
Q3 		$1.07M Buy
40,154
+21,306
+113% +$482K ﹤0.01% 4489
2018
Q2 		$431K Buy
18,848
+17,316
+1,130% +$378K ﹤0.01% 5194
2018
Q1 		$33K Buy
1,532
+841
+122% +$12.8K ﹤0.01% 6002
2017
Q4 		$9K Sell
691
-1,938
-74% -$26K ﹤0.01% 6243
2017
Q3 		$41K Sell
2,629
-566
-18% -$6.88K ﹤0.01% 5842
2017
Q2 		$37K Sell
3,195
-11,295
-78% -$140K ﹤0.01% 5936
2017
Q1 		$170K Sell
14,490
-18,440
-56% -$211K ﹤0.01% 5397
2016
Q4 		$410K Buy
+32,930
New +$382K ﹤0.01% 5041

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's MYOV Position: Q1 2023 in Review

Morgan Stanley sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 461,060 shares — an estimated $12.4M sold.

Morgan Stanley first reported a position in MYOV in Q4 2016 and held it in 25 quarters. The position peaked at $12.4M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Morgan Stanley reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 461,060 Myovant Sciences Ltd. shares in Q1 2023, an estimated $12.4M.
  • Morgan Stanley first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 25 quarters.
  • Morgan Stanley's Myovant Sciences Ltd. position peaked at $12.4M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.